Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−53 JPY
−2.39 B JPY
0.00 JPY
61.68 M
About MODALIS THERAPEUTICS CORP
Sector
Industry
CEO
Haru Morita
Website
Headquarters
Tokyo
Founded
2016
ISIN
JP3922600006
FIGI
BBG00VR4B2M2
Modalis Therapeutics Corp. engages in the development of gene therapy drugs. It uses CRISPR-GNDM, a gene modulation technology that assists patients fighting with genetic disorders. The company was founded by Haruhiko Morita and Osamu Nureki in January 2016 and is headquartered in Tokyo, Japan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4883 is 141 JPY — it has increased by 6.02% in the past 24 hours. Watch MODALIS THERAPEUTICS CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange MODALIS THERAPEUTICS CORP stocks are traded under the ticker 4883.
4883 stock has risen by 25.89% compared to the previous week, the month change is a 48.42% rise, over the last year MODALIS THERAPEUTICS CORP has showed a 10.16% increase.
4883 reached its all-time high on Aug 25, 2020 with the price of 4,070 JPY, and its all-time low was 62 JPY and was reached on May 17, 2024. View more price dynamics on 4883 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4883 stock is 8.96% volatile and has beta coefficient of −0.23. Track MODALIS THERAPEUTICS CORP stock price on the chart and check out the list of the most volatile stocks — is MODALIS THERAPEUTICS CORP there?
Today MODALIS THERAPEUTICS CORP has the market capitalization of 9.79 B, it has increased by 7.26% over the last week.
Yes, you can track MODALIS THERAPEUTICS CORP financials in yearly and quarterly reports right on TradingView.
MODALIS THERAPEUTICS CORP is going to release the next earnings report on Feb 17, 2025. Keep track of upcoming events with our Earnings Calendar.
4883 net income for the last quarter is −279.29 M JPY, while the quarter before that showed −323.01 M JPY of net income which accounts for 13.54% change. Track more MODALIS THERAPEUTICS CORP financial stats to get the full picture.
No, 4883 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 24, 2024, the company has 37.00 employees. See our rating of the largest employees — is MODALIS THERAPEUTICS CORP on this list?
Like other stocks, 4883 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MODALIS THERAPEUTICS CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MODALIS THERAPEUTICS CORP technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MODALIS THERAPEUTICS CORP stock shows the neutral signal. See more of MODALIS THERAPEUTICS CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.